Amelioration of adriamycin toxicity through modification of drug-DNA binding properties.
Israel
M
M
Department of Pharmacology, University of Tennessee, Memphis.
Seshadri
R
R
Koseki
Y
Y
Sweatman
T W
TW
Idriss
J M
JM
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA / Q000378:metabolism*; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; D004247:DNA